Overview Quote
Stock Activity
| Day Low - High | 0.14 - 0.15 |
| 52wk Low - High | 0.11 - 0.30 |
| Previous Close | 0.15 |
| Avg. Volume | 362,177 |
| Industry | MED PRODUCTS |
| Market Cap | 7.66 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 1.63 |
| PE (Forward) | 0.00 |
| Current Year Est. | -0.10 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
NA |
Zacks Industry Rank
|
175 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Company Description
PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Headquartered in Franklin, Mass., PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization to alleviate symptoms of severe angina. CO2 TMR offers a treatment option for angina patients who suffer from severe coronary artery disease. The CO2 Heart Laser is the world's first TMR angina relief device approved by both the U.S. Food and Drug Administration and Japanese Ministry of Health, Labor and Welfare. In a move to broaden its market, the company recently announced its intention to initiate clinical studies for its RenalGuard Therapy and RenalGuard System. RenalGuard Therapy is designed to reduce the toxic effects that contrast media can have on the kidneys. It is based on the theory that creating and maintaining a high urine output is beneficial to patients undergoing imaging procedures where contrast agents are used.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Earnings Estimates
| Current Qtr (03/2013) |
Next Qtr (06/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | -0.03 | -0.02 | -0.10 | -0.05 |
| Number of Estimates | 2 | 2 | 2 | 2 |
| Low Estimate | -0.03 | -0.02 | -0.11 | -0.08 |
| High Estimate | -0.03 | -0.02 | -0.09 | NA |
| Year Ago EPS | -0.04 | -0.04 | -0.21 | -0.10 |
| EPS Growth | 25.00% | 50.00% | 52.38% | 45.00% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| PLC SYSTEMS INC | PLCSF | 0.14 | ![]() |
![]() |
| CONCEPTUS INC | CPTS | 30.92 | ![]() |
![]() |
| ATRICURE INC | ATRC | 9.07 | ![]() |
![]() |
| CYTOSORBENTS CP | CTSO | 0.12 | ![]() |
![]() |
| INVIVO THERAPT | NVIV | 2.89 | ![]() |
![]() |
| TRANS1 INC | TSON | 1.70 | ![]() |
![]() |
| ABAXIS INC | ABAX | 45.35 | ![]() |
![]() |
| ADVAXIS INC | ADXS | 0.05 | ![]() |
![]() |
| ALERE INC | ALR | 26.30 | ![]() |
![]() |
| BAXTER INTL | BAX | 72.94 | ![]() |
![]() |
Sector:Medical>> Industry:MED PRODUCTS
Zacks Commentary
Int'l Sales Ramping Nicely. Maintaining Outperform
May 16, 2013
Symmetry Launches New FlashPak
Mar 11, 2013
Alere Extends Deal with Virtua
Mar 08, 2013
Q3 Results In-Line. Maintaining Outperform Rec.
Nov 19, 2012
PLCSF: Initiating Coverage of PLC Systems Inc.
Nov 05, 2012
Report Not Available
Financials
| EPS TTM | -0.02 |
| Sales | 1 |
| Net Income | -2 |
| Price/Earnings | NA |
| Price/Book | NA |
| Price/Cash Flow | NA |
| Price/Sales | 7.09 |
News
PLC Systems Demonstrating RenalGuard(R) at EuroPCR2013 - Marketwire
May 16, 2013
PLC Systems Reports First Quarter 2013 Financial Results - Marketwire
May 15, 2013
RenalGuard Clinical Data Presented at International Conference of theIsrael Heart Society - Marketwire
May 7, 2013
PLC Systems to Present at Taglich Brothers 10th Annual Small CapEquity Conference - Marketwire
May 2, 2013
PLC Systems Receives First European Patent for RenalGuard(R) - Marketwire
May 1, 2013
PLC Systems Inc. Launches New Corporate Website Including a Suite ofOnline Digital Corporate Communication Channels - Marketwire
Apr 29, 2013
PLC Medical Systems To Present At Taglich Brothers 10th Annual Small Cap Equity Conference - Globenewswire
Apr 22, 2013
PLC Systems 2012 Financial Results Feature RenalGuard Sales up 157% for the Fourth Quarter and 96% for the Full Year - Businesswire
Mar 28, 2013
Broker Recommendations
| Current ABR | 1.50 |
| ABR (Last Week) | 1.50 |
| # of recs in ABR | 2 |
| Average Target Price | 0.46 |
| Industry Rank by ABR | 175 out of 265 |
| Rank in Industry | 6 out of 72 |

3